These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1347541)

  • 1. Proteinuria and microalbuminuria as predictors of nephropathy.
    Arieff AI
    Hosp Pract (Off Ed); 1992 Feb; 27 Suppl 1():51-4. PubMed ID: 1347541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium-lithium countertransport activity in red cells of patients with insulin dependent diabetes and nephropathy and their parents.
    Walker JD; Tariq T; Viberti G
    BMJ; 1990 Sep; 301(6753):635-8. PubMed ID: 2224216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteinuria and microalbuminuria in adults: significance, evaluation, and treatment.
    Venkat KK
    South Med J; 2004 Oct; 97(10):969-79. PubMed ID: 15558924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diabetic nephropathy: natural history and therapeutic interventions].
    Scheen AJ
    Rev Med Liege; 1993 Dec; 48(12):645-58. PubMed ID: 8310199
    [No Abstract]   [Full Text] [Related]  

  • 5. Controversies on the prevention of diabetic nephropathy.
    Chiarelli F; Verrotti A; Basciani F; di Ricco L; Sabatino G; Morgese G
    J Pediatr Endocrinol Metab; 1998 Apr; 11 Suppl 2():365-9. PubMed ID: 9642666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interventions based on microalbuminuria screening and low-protein diet in the treatment of kidney disease of diabetes mellitus.
    Viberti GC
    Am J Kidney Dis; 1989 Jan; 13(1):41-4. PubMed ID: 2643309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of progression from microalbuminuria to proteinuria in patients who have type 1 diabetes and are treated with angiotensin-converting enzyme inhibitors.
    Ficociello LH; Perkins BA; Silva KH; Finkelstein DM; Ignatowska-Switalska H; Gaciong Z; Cupples LA; Aschengrau A; Warram JH; Krolewski AS
    Clin J Am Soc Nephrol; 2007 May; 2(3):461-9. PubMed ID: 17699452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
    Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S
    Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetic nephropathy in children and adolescents: a critical review with particular reference to angiotensin-converting enzyme inhibitors.
    Chiarelli F; Casani A; Verrotti A; Morgese G; Pinelli L
    Acta Paediatr Suppl; 1998 Oct; 425():42-5. PubMed ID: 9822193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteinuria and renal function in diabetic patients fed a diet moderately restricted in protein.
    Yue DK; O'Dea J; Stewart P; Conigrave AD; Hosking M; Tsang J; Hall B; Dale N; Turtle JR
    Am J Clin Nutr; 1988 Aug; 48(2):230-4. PubMed ID: 3407603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetic nephropathy: early detection, prevention and management.
    Maher JF
    Am Fam Physician; 1992 Apr; 45(4):1661-8. PubMed ID: 1558042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of diabetic nephropathies].
    Arakawa M; Suzuki Y
    Nihon Naika Gakkai Zasshi; 1994 Sep; 83(9):1642-7. PubMed ID: 7798763
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of ACE-inhibitor therapy on renal disease in glycogen storage disease type 1: a multicentre retrospective study.
    Melis D; Parenti G; Gatti R; Casa RD; Parini R; Riva E; Burlina AB; Dionisi Vici C; Di Rocco M; Furlan F; Torcoletti M; Papadia F; Donati A; Benigno V; Andria G
    Clin Endocrinol (Oxf); 2005 Jul; 63(1):19-25. PubMed ID: 15963056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical relevance of proteinuria and microalbuminuria.
    Ruilope LM; Rodicio JL
    Curr Opin Nephrol Hypertens; 1993 Nov; 2(6):962-7. PubMed ID: 7922240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
    Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
    Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The kidney in diabetes: significance of the early abnormalities.
    Viberti GC; Wiseman MJ
    Clin Endocrinol Metab; 1986 Nov; 15(4):753-82. PubMed ID: 3536199
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of an ACE inhibitor/calcium antagonist combination on proteinuria in diabetic nephropathy.
    Bakris GL; Weir MR; DeQuattro V; McMahon FG
    Kidney Int; 1998 Oct; 54(4):1283-9. PubMed ID: 9767545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention and treatment of renal disease in insulin-dependent diabetes mellitus.
    Mogensen CE
    Semin Nephrol; 1990 May; 10(3):260-73. PubMed ID: 2190283
    [No Abstract]   [Full Text] [Related]  

  • 19. The emerging concept of chronic kidney disease without clinical proteinuria in diabetic patients.
    Halimi JM
    Diabetes Metab; 2012 Oct; 38(4):291-7. PubMed ID: 22622176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting the development of diabetic nephropathy and its progression.
    William J; Hogan D; Batlle D
    Adv Chronic Kidney Dis; 2005 Apr; 12(2):202-11. PubMed ID: 15822056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.